Cleeland C S, Gonin R, Hatfield A K, Edmonson J H, Blum R H, Stewart J A, Pandya K J
Pain Research Group, Department of Neurology, Madison, WI 53705-4013.
N Engl J Med. 1994 Mar 3;330(9):592-6. doi: 10.1056/NEJM199403033300902.
Pain is often inadequately treated in patients with cancer. A total of 1308 outpatients with metastatic cancer from 54 treatment locations affiliated with the Eastern Cooperative Oncology Group rated the severity of their pain during the preceding week, as well as the degree of pain-related functional impairment and the degree of relief provided by analgesic drugs. Their physicians attributed the pain to various factors, described its treatment, and estimated the impact of pain on the patients' ability to function. We assessed the adequacy of prescribed analgesic drugs using guidelines developed by the World Health Organization, studied the factors that influenced whether analgesia was adequate, and determined the effects of inadequate analgesia on the patients' perception of pain relief and functional status.
Sixty-seven percent of the patients (871 of 1308) reported that they had had pain or had taken analgesic drugs daily during the week preceding the study, and 36 percent (475 of 1308) had pain severe enough to impair their ability to function. Forty-two percent of those with pain (250 of the 597 patients for whom we had complete information) were not given adequate analgesic therapy. Patients seen at centers that treated predominantly minorities were three times more likely than those treated elsewhere to have inadequate pain management. A discrepancy between patient and physician in judging the severity of the patient's pain was predictive of inadequate pain management (odds ratio, 2.3). Other factors that predicted inadequate pain management included pain that physicians did not attribute to cancer (odds ratio, 1.9), better performance status (odds ratio, 1.8), age of 70 years or older (odds ratio, 2.4), and female sex (odds ratio, 1.5). Patients with less adequate analgesia reported less pain relief and greater pain-related impairment of function.
Despite published guidelines for pain management, many patients with cancer have considerable pain and receive inadequate analgesia.
癌症患者的疼痛常常未得到充分治疗。东部肿瘤协作组下属54个治疗点的1308例转移性癌症门诊患者对其前一周的疼痛严重程度、疼痛相关功能障碍程度以及镇痛药提供的缓解程度进行了评分。他们的医生将疼痛归因于各种因素,描述了疼痛的治疗情况,并估计了疼痛对患者功能能力的影响。我们使用世界卫生组织制定的指南评估了所开镇痛药的充分性,研究了影响镇痛是否充分的因素,并确定了镇痛不充分对患者疼痛缓解感知和功能状态的影响。
67%的患者(1308例中的871例)报告称在研究前一周内有疼痛或每日服用镇痛药,36%(1308例中的475例)的疼痛严重到足以损害其功能能力。有疼痛的患者中,42%(在我们有完整信息的597例患者中的250例)未得到充分的镇痛治疗。主要治疗少数族裔患者的中心的患者疼痛管理不充分的可能性是其他中心患者的三倍。患者与医生在判断患者疼痛严重程度上的差异预示着疼痛管理不充分(优势比为2.3)。其他预示疼痛管理不充分的因素包括医生未归因于癌症的疼痛(优势比为1.9)、较好的体能状态(优势比为1.8)、70岁及以上的年龄(优势比为2.4)以及女性(优势比为1.5)。镇痛效果较差的患者报告的疼痛缓解较少,且与疼痛相关的功能损害更大。
尽管有已发表的疼痛管理指南,但许多癌症患者仍有相当程度的疼痛且镇痛不充分。